Seeking Alpha


Send Message
View as an RSS Feed
View nikeherc1's Comments BY TICKER:
Latest  |  Highest rated
  • Peregrine Pharma, AstraZeneca to collaborate on immuno-oncology trial [View news story]
    Read the Barron's front page article on new cancer therapies. Immune oncology I/O is in the forefront of much research now.
    Aug 25, 2015. 06:36 PM | Likes Like |Link to Comment
  • How Low Can Twitter Go? [View article]
    Noto is the only insider buying the TWTR
    Aug 7, 2015. 07:21 PM | 4 Likes Like |Link to Comment
  • PSA: Afrezza Is NOT Exubera [View article]
    This morning "The" is saying Sanofi will drop MannKind in January due to poor sales. They have hated MannKind from day one..
    Jul 3, 2015. 12:46 PM | Likes Like |Link to Comment
  • MannKind Valuation Scenarios [View article]
    I like your math...
    Mar 31, 2015. 12:09 PM | 2 Likes Like |Link to Comment
  • Skip Peregrine Pharmaceuticals For 2015 [View article]
    It sells for $1.50 a share. It's a speculation, plain and simple. If it goes, one could make a lot of money. If not, it's not like betting the house. Any one of these products could prove to be a ten bagger. I own it for the long term and do not listen to negative BS. Also, big Pharma is looking to add to their pipelines.
    Mar 25, 2015. 06:30 PM | 12 Likes Like |Link to Comment
  • Jefferies lowers MannKind price target 10% due to longer ramp [View news story]
    Thank you
    Mar 24, 2015. 05:45 PM | 2 Likes Like |Link to Comment
  • I Bought AT&T For The First Time And This Is Why [View article]
    i agree. It's in my IRA, think about this, the Required Minimum Distribution (RMD) at age 70 1/2 is just under 4% a year. T pays 5.6% dividend. So rather than my IRA depreciating, it is gaining in value by the excess in dividend income. And people keep paying those cell phone bills. DTV is the next cash cow.
    Mar 24, 2015. 05:37 PM | 6 Likes Like |Link to Comment
  • It's Time To Turn Bearish On Rackspace, Again! [View article]
    Somebody must feel they're worth the price.
    Mar 12, 2015. 09:00 PM | Likes Like |Link to Comment
  • Generex successful in increasing insulin concentration in spray product candidate [View news story]
    This is a joke. All we can do is laugh and shake our heads.
    Mar 12, 2015. 08:50 PM | 1 Like Like |Link to Comment
  • A Close-Up Look At The Report That Had MannKind Investors Reeling [View article]
    Goldman is a heavyweight. That does not make them always right.
    Last spring they were calling for $200 oil. Today they are calling for $40 oil.
    Just look at the numbers, 30 million diabetics in the US, 380 million globally. My bet is on MNKD. As Janet Yellen would say "patience".....
    Mar 9, 2015. 07:07 PM | 11 Likes Like |Link to Comment
  • InvenSense +6.5%; Friday short-covering at work? [View news story]
    Don't get me wrong I'm glad I own it and did average down when they were advising us to buy. It's just that right after their last recommendation someone from their staff puts out a "time to sell" advisory, one has to wonder who's editing this stuff. Long term I have done well with the fool.
    Dec 6, 2014. 03:25 PM | Likes Like |Link to Comment
  • InvenSense +6.5%; Friday short-covering at work? [View news story]
    Some of the reply's to Motley Fool:
    Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

    Report this Comment On November 25, 2014, at 2:58 PM, glr wrote:
    I sold this stock every time before earnings, except this time. Mistake, but at least I do not have a loss on the stock considering the trades I made. I also see it as going nowhere.

    Report this Comment On November 25, 2014, at 3:04 PM, hellooooo wrote:
    Funny how you guys were the ones pumping this POS

    Report this Comment On November 25, 2014, at 3:07 PM, WSJNC wrote:
    Well finally the Fool is setting up to take the Buy Now rec down with yesterdays article and this article today after the 40% and falling decline.

    What really is a shame is how Eassa pumped the stock with his merger article last week so he could get out of his position at 16.

    Its headed under $14 this week now after the failed rally, but it got him out of his position and fool sold subscriptions. Time to move onto the next video mass marketing scam.

    Perhaps the iwatch will have some really cool strap.

    Report this Comment On November 25, 2014, at 3:14 PM, kildon42 wrote:
    I have a small position and am willing to wait. The big question is not quick profits, but which company has the best products and forward ideas. THIS IS THE COMPANY THAT EVENTUALLY WILL WIN OUT.

    Report this Comment On November 25, 2014, at 4:42 PM, BabyStinky wrote:
    This is hilarious given MF's emails yesterday (Scorecard News: INVN) stating "the MDP team still thinks today's stock price gives investors an excellent long-term opportunity."

    What the hell am I paying you guys all this money for? I bought more based on this and now a day later you are saying sell it???

    Make up your minds and let us know!
    Dec 6, 2014. 03:13 PM | Likes Like |Link to Comment
  • InvenSense +6.5%; Friday short-covering at work? [View news story]
    Yes, Rule Breakers:
    It's Time to Sell InvenSense Stock. Here's Why.
    By Rich Smith | More Articles | Save For Later
    November 25, 2014 | Comments (16)

    Shares of InvenSense (NYSE: INVN ) are down 10% over the past year, underperforming rivals Analog Devices (NASDAQ: ADI ) , and STMicroelectronics (NYSE: STM ) . Owners of InvenSense stock might be loathe to eat their losses and sell the stock, but I think that's precisely the thing to do now. And I'll tell you why.

    InvenSense stock costs too much
    Even with that 10$ haircut, InvenSense stock remains the most expensive of the three big players in micro-electro-mechanical system, or MEMS, gyroscopes, which are used for motion-tracking functions in consumer electronics.

    At a forward price-to-earnings ratio of 20, InvenSense stock sells for 20 times the profits the currently unprofitable company might earn next year. That makes the shares about 2.5% pricier than those of barely profitable STMicro, and 9% more expensive than cheapest of the bunch Analog Devices.
    Enough said.....
    Dec 6, 2014. 03:10 PM | Likes Like |Link to Comment
  • InvenSense +6.5%; Friday short-covering at work? [View news story]
    Glad I didn't follow Motley Fool's advice and sold this week. They proved how worthless they are by advising us to buy three weeks ago and changing their mind just weeks later. Long
    Dec 5, 2014. 12:21 PM | 3 Likes Like |Link to Comment
  • Examining Dividend Aristocrats: AT&T Approaching Value [View article]
    For those of us approaching RMD's in our retirement accounts the three stocks you mentioned are perfect. The RMD (retirement minimum distribution) is around 4%. With the telephone stocks paying an average of 4.5%. The hardest thing you have to do is go to the mailbox and collect your check. I would add VOD to your portfolio as well.
    Sep 6, 2014. 03:04 PM | Likes Like |Link to Comment